FdaApplication
NDA 212527
Identifiers
- fda_app_no: NDA212527
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA USA INC. |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE | DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE | EQ 50MG BASE | TABLET |
1 product